Abstract
Current Pharmaceutical Design
Title: Editorial [Hot Topic: DNA Anti-Cancer Drug Design (Executive Editor: Naijie Jing)]
Volume: 11 Issue: 22
Author(s): Naijie Jing
Affiliation:
Abstract:
Export Options
About this article
Cite this article as:
Jing Naijie, Editorial [Hot Topic: DNA Anti-Cancer Drug Design (Executive Editor: Naijie Jing)], Current Pharmaceutical Design 2005; 11 (22) . https://dx.doi.org/10.2174/1381612054546734
DOI https://dx.doi.org/10.2174/1381612054546734 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
Call for Papers in Thematic Issues
"Tuberculosis Prevention, Diagnosis and Drug Discovery"
The Nobel Prize-winning discoveries of Mycobacterium tuberculosis and streptomycin have enabled an appropriate diagnosis and an effective treatment of tuberculosis (TB). Since then, many newer diagnosis methods and drugs have been saving millions of lives. Despite advances in the past, TB is still a leading cause of infectious disease mortality ...read more
Current Pharmaceutical challenges in the treatment and diagnosis of neurological dysfunctions
Neurological dysfunctions (MND, ALS, MS, PD, AD, HD, ALS, Autism, OCD etc..) present significant challenges in both diagnosis and treatment, often necessitating innovative approaches and therapeutic interventions. This thematic issue aims to explore the current pharmaceutical landscape surrounding neurological disorders, shedding light on the challenges faced by researchers, clinicians, and ...read more
Emerging and re-emerging diseases
Faced with a possible endemic situation of COVID-19, the world has experienced two important phenomena, the emergence of new infectious diseases and/or the resurgence of previously eradicated infectious diseases. Furthermore, the geographic distribution of such diseases has also undergone changes. This context, in turn, may have a strong relationship with ...read more
Melanoma and Non-Melanoma Skin Cancer Treatment: Standard of Care and Recent Advances
In this thematic issue, we aim to provide a standard of care of the diagnosis and treatment of melanoma and non-melanoma skin cancer. The editor will invite authors from different countries who will write review articles of melanoma and non-melanoma skin cancers. The Diagnosis, Staging, Surgical Treatment, Non-Surgical Treatment all ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Emerging Role of Connexin 43 in Testis Pathogenesis
Current Molecular Medicine Synthesis of New Bis-Spiropyrazoles as Antitumor Agents under Ultrasound Irradiation
Mini-Reviews in Medicinal Chemistry Indole Compounds Against Breast Cancer: Recent Developments
Current Drug Targets Glucose Oncometabolism of Esophageal Cancer
Anti-Cancer Agents in Medicinal Chemistry Delivery of Therapeutics and Molecules Using Self-Assembled Peptides
Current Medicinal Chemistry Oxaliplatin-mediated Inhibition of Survivin Increases Sensitivity of Head and Neck Squamous Cell Carcinoma Cell Lines to Paclitaxel
Current Cancer Drug Targets Permanent Implantation as Brachytherapy Technique for Prostate Carcinoma-Review of Clinical Trials and Guidelines
Reviews on Recent Clinical Trials Lycopene and Cardiovascular Diseases: An Update
Current Medicinal Chemistry Editorial [Hot topic: Receptor-Targeted Cancer Therapy (Guest Editor: Li-Chun Sun)]
Current Drug Delivery The Antioxidants and Pro-Antioxidants Network: An Overview
Current Pharmaceutical Design Lymphangiogenesis and Anti-Tumor Immune Responses
Current Molecular Medicine Potential Prophylactic and Therapeutic Vaccines for HSV Infections
Current Pharmaceutical Design Applications of Natural Polymeric Materials in Solid Oral Modified-Release Dosage Forms
Current Pharmaceutical Design Therapeutic Perspectives on Pancreatic Cancer
Current Cancer Drug Targets Specific Recognition of DNA by Small Molecules
Current Medicinal Chemistry METCAM/MUC18 Expression and Cancer Metastasis
Current Genomics Pleiotropic Effects of Omega-3 Fatty Acids
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Tailored Multi-Target Agents. Applications and Design Considerations
Current Pharmaceutical Design Lessons in Medical Record Abstraction from the Prostate, Lung, Colorectal, and Ovarian (PLCO) National Screening Trial
Reviews on Recent Clinical Trials Biomedical Applications of Nanomaterials Containing Gadolinium
Current Inorganic Chemistry (Discontinued)